Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1998
10/27/1998US5827658 Isolation of amplified genes via cDNA subtractive hybridization
10/27/1998US5827657 Direct cloning of PCR amplified nucleic acids
10/27/1998US5827656 Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences
10/27/1998US5827655 Product of the mk3 gene; identifying immune response
10/27/1998US5827653 Nucleic acid detection with energy transfer
10/27/1998US5827649 For simplified determination of polynucleotide analyte
10/27/1998US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits
10/27/1998US5827646 Comprising isolated epstein barr virus structural antigen and epstein barr nuclear antigen 1
10/27/1998US5827642 Adding lymphocyte population to culture medium in vitro, adding non-dividing peripheral blood mononuclear cells as feeder cells, adding non-dividing lymphoblastoid cells, adding monoclonal antibody, incubating culture
10/27/1998US5827519 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
10/27/1998US5827515 Obtaining a dna segemnt containing spov dna sequence, introducing the segment into a bacillus thuringiensis host, isolating genetically engineered mutant capable of expressing exogenous crystal protein
10/27/1998US5827514 Pesticidal compositions
10/27/1998US5827482 Transistor-based apparatus and method for molecular detection and field enhancement
10/27/1998US5827480 Nucleic acid amplification reaction apparatus
10/27/1998CA2078694C Hepatitis b vaccine
10/27/1998CA2049017C Human-derived glycoprotein, biologically active factor which includes glyoprotein, and pharmaceutical product which comprises biologically active factor as active component
10/27/1998CA1340103C Cloning of dna for protozoal antigens
10/27/1998CA1340101C Amylolytic enzymes producing microorganisms, constructed by recombinant dna technology and their use for fermentation processes
10/27/1998CA1340100C Polynucleotide commposition and method
10/27/1998CA1340099C Method for in vitro immunisation of lymphocytes for use in production ofhuman monoclonal antibodies and kit therefor
10/24/1998CA2228743A1 Novel integrin ligand itgl-tsp
10/22/1998WO1998047089A1 Apparatus and method for automated protein design
10/22/1998WO1998046797A1 Nucleic acid archiving
10/22/1998WO1998046796A1 A method of screening nucleotide sequences to identify disruptors or effectors of biological processes or pathways
10/22/1998WO1998046795A1 Method for detection of recurrent prostate cancer
10/22/1998WO1998046791A1 Uses of calculus
10/22/1998WO1998046790A1 Hybridisation assay in which excess probe is destroyed
10/22/1998WO1998046788A2 Primers and methods for the detection of disseminated tumor cells
10/22/1998WO1998046785A1 Dendritic cell hybrids
10/22/1998WO1998046781A2 Novel transgene expression system for increased persistence
10/22/1998WO1998046780A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression
10/22/1998WO1998046779A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3
10/22/1998WO1998046778A1 Transgenomic viruses and the use thereof
10/22/1998WO1998046777A1 Preparing membrane receptors from extracellular baciloviruses
10/22/1998WO1998046776A2 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids
10/22/1998WO1998046775A1 Oxidative stress resistance gene
10/22/1998WO1998046774A1 Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal rna encoding domain, particularly with kluyveromyces
10/22/1998WO1998046773A1 Gene involved in basidiomycete fungi fruit body development and uses
10/22/1998WO1998046772A2 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
10/22/1998WO1998046771A2 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same, related proteases, and therapeutic uses thereof
10/22/1998WO1998046770A2 Stable biocatalysts for ester hydrolysis
10/22/1998WO1998046769A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998WO1998046768A2 Phenolic acid esterase and use thereof
10/22/1998WO1998046767A1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
10/22/1998WO1998046766A1 Nucleic acids encoding a plant enzyme involved in very long chain fatty acid synthesis
10/22/1998WO1998046765A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998WO1998046764A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
10/22/1998WO1998046763A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998WO1998046762A1 Plant fatty acid epoxygenase genes and uses therefor
10/22/1998WO1998046761A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
10/22/1998WO1998046760A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin
10/22/1998WO1998046759A2 Plants with controlled side-shoot formation and/or controlled abscission area formation
10/22/1998WO1998046758A1 Human tumor-associated kazal inhibitor
10/22/1998WO1998046757A2 Secreted proteins and polynucleotides encoding them
10/22/1998WO1998046756A1 Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
10/22/1998WO1998046755A1 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
10/22/1998WO1998046754A1 Human rho protein
10/22/1998WO1998046753A1 Regulator of gene transcription
10/22/1998WO1998046752A1 Human transmembrane protein
10/22/1998WO1998046751A1 Osteoprotegerin binding proteins and receptors
10/22/1998WO1998046750A1 flt3 LIGAND CHIMERIC PROTEINS
10/22/1998WO1998046749A1 A nitrobenzylmercaptopurineriboside (nbmpr)-insensitive, equilibrative, nucleoside transport protein, nucleic acids encoding the same and methods of use
10/22/1998WO1998046748A1 Therapeutic compositions and diagnostic assays for diseases involving trbp
10/22/1998WO1998046747A2 Genes in the non-recombining region of the y chromosome
10/22/1998WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998WO1998046745A1 NOVEL dlg FAMILY MOLECULE, POLYNUCLEOTIDE ENCODING THE SAME, ANTIBODY AGAINST THE SAME, AND METHOD FOR DETECTING dlg GENE
10/22/1998WO1998046744A1 Intracellular interactors and eh domain binding specificity
10/22/1998WO1998046743A1 Novel ldl-receptor
10/22/1998WO1998046742A2 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination
10/22/1998WO1998046740A1 Method of treating restenosis by antisense targeting of cmv
10/22/1998WO1998046735A1 Animal models of growth hormone insensitivity
10/22/1998WO1998046734A1 Transgenic mouse expressing human cd4 and fusin (cxcr4)
10/22/1998WO1998046733A1 Chromosome transfer (xmmct) to es cells, induced during the exposure of microcells to radiation
10/22/1998WO1998046730A1 Human phosphatidic acid phosphatase
10/22/1998WO1998046729A2 Enzyme assay for mutant firefly luciferase
10/22/1998WO1998046728A1 Methods for increasing the efficiency of recombinant aav product
10/22/1998WO1998046724A1 RECOMBINANT bHLH-PAS/JHR POLYPEPTIDE AND ITS USE TO SCREEN POTENTIAL INSECTICIDES
10/22/1998WO1998046722A1 Direct expression of peptides into culture media
10/22/1998WO1998046645A2 Method for the production of antihuman antigen receptors and uses thereof
10/22/1998WO1998046644A1 Novel protein and process for producing the same
10/22/1998WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998WO1998046641A1 Novel polypeptides within the growth factor superfamily
10/22/1998WO1998046638A1 A novel th2-specific gene
10/22/1998WO1998046636A2 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
10/22/1998WO1998046633A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998WO1998046621A1 Improvements in adaptor-based sequence analysis
10/22/1998WO1998046619A1 Glycine transporter
10/22/1998WO1998046274A2 Cationic polymers for nucleic acid transfection
10/22/1998WO1998046273A2 Delivery system for gene therapy to the brain
10/22/1998WO1998046272A1 Antisense oligonucleotide compositions and methods for the modulation of activating protein 1
10/22/1998WO1998046271A1 Process for infecting eukaryotic cells with a bacterial virus
10/22/1998WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046260A1 Pasteurella haemolytica vaccine
10/22/1998WO1998046259A1 Non-antibiotic system for selection of recombinant mycobacteria
10/22/1998WO1998046257A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
10/22/1998WO1998046208A1 Hair follicle dna delivery system
10/22/1998WO1998046083A1 Use of lentiviral vectors for antigen presentation in dendritic cells
10/22/1998WO1998036068A3 Human p24 vesicle proteins
10/22/1998WO1998035028A3 An oncolytic/immunogenic complementary-adenoviral vector system
1 ... 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 ... 4023